Search research articles
Contact Us
Filters
Showing results (121-130 of 200) with videos related to
Page
of 20
Sort By:
Drug Design, Development and Therapy
|
July 20, 2022
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D Smith, Lynn W Maines, Staci N Keller, et al.
Psychiatry Research
|
July 11, 2013
Dopaminergic modulation of memory and affective processing in Parkinson depression
Lee X Blonder, John T Slevin, Richard J Kryscio, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 7, 2009
MRI diffusion tensor tracking of a new amygdalo-fusiform and hippocampo-fusiform pathway system in humans
Charles D Smith, Nicolas F Lori, Erbil Akbudak, et al.
Cancer Biology & Therapy
|
December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma
Sharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Journal of Alzheimer'S Disease : JAD
|
April 22, 2006
Alzheimer's disease and head circumference
Patricio S Espinosa, Richard J Kryscio, Marta S Mendiondo, et al.
Plos One
|
October 3, 2013
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis
Junaid Abdulghani, Joshua E Allen, David T Dicker, et al.
Brain Research. Cognitive Brain Research
|
July 23, 2004
Regional brain response to faces of humans and dogs
Lee X Blonder, Charles D Smith, C Ervin Davis, et al.
Neuroimage. Clinical
|
January 23, 2015
Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease
Joseph C McBride, Xiaopeng Zhao, Nancy B Munro, et al.
Digestive Diseases and Sciences
|
December 7, 2007
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase
Lynn W Maines, Leo R Fitzpatrick, Kevin J French, et al.
Molecular Cancer Therapeutics
|
August 8, 2006
Discovery and characterization of inhibitors of human palmitoyl acyltransferases
Charles E Ducker, Lindsay K Griffel, Ryan A Smith, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 200) with videos related to
Sort By:
Page
of 20
Drug Design, Development and Therapy
|
July 20, 2022
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D Smith, Lynn W Maines, Staci N Keller, et al.
Psychiatry Research
|
July 11, 2013
Dopaminergic modulation of memory and affective processing in Parkinson depression
Lee X Blonder, John T Slevin, Richard J Kryscio, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 7, 2009
MRI diffusion tensor tracking of a new amygdalo-fusiform and hippocampo-fusiform pathway system in humans
Charles D Smith, Nicolas F Lori, Erbil Akbudak, et al.
Cancer Biology & Therapy
|
December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma
Sharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Journal of Alzheimer'S Disease : JAD
|
April 22, 2006
Alzheimer's disease and head circumference
Patricio S Espinosa, Richard J Kryscio, Marta S Mendiondo, et al.
Plos One
|
October 3, 2013
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis
Junaid Abdulghani, Joshua E Allen, David T Dicker, et al.
Brain Research. Cognitive Brain Research
|
July 23, 2004
Regional brain response to faces of humans and dogs
Lee X Blonder, Charles D Smith, C Ervin Davis, et al.
Neuroimage. Clinical
|
January 23, 2015
Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease
Joseph C McBride, Xiaopeng Zhao, Nancy B Munro, et al.
Digestive Diseases and Sciences
|
December 7, 2007
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase
Lynn W Maines, Leo R Fitzpatrick, Kevin J French, et al.
Molecular Cancer Therapeutics
|
August 8, 2006
Discovery and characterization of inhibitors of human palmitoyl acyltransferases
Charles E Ducker, Lindsay K Griffel, Ryan A Smith, et al.
Page
of 20